Method for mass spectrometric detection of coenzyme A and metabolites of biological sample
By obtaining cell samples, tissue cells and bodily fluid tissue, and LC-MS detection was performed after enrichment of TCA and SPE columns, the problems of low mass spectrometry signal and large sample consumption in the prior art were solved, and the mammalian coenzyme A-related substances were realized efficient detection, suitable for clinical samples and large-scale detection.
Patent Information
- Application Number
- CN202411228876.1
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-09-03
- Publication Date
- 2024-11-12
AI Technical Summary
The mass spectrometry signal of the existing biological sample mass spectrometry detection methods is low and consumes a large amount of biological samples, which makes it difficult to increase the sample size for mammalian functional cells and cannot detect Coenzyme A-related substances.
After obtaining cell samples, tissue cells and body fluid tissue, the rapid mass spectrometry detection method of short-chain fatty acid-CoA, including enrichment, elution and drying of TCA and SPE columns, and finally 20 types were performed by LC-MS detection method. Detection of short-chain fatty acid-Coenzyme A molecules.
The required biological sample size is reduced, the detection signal is improved, the detection time is short, suitable for clinical samples, and the samples can be stored and tested within 48 hours, suitable for large-scale sample testing.
Smart Images

Figure CN118937462A_ABST
Abstract
Description
Technical Field
[0001] The present invention relates to the technical field of biological analysis and detection, and in particular to a method for detecting coenzyme A and metabolites by mass spectrometry of biological samples. Background Art
[0002] Coenzyme A is a coenzyme that is widely present in organisms and plays a vital role in maintaining life activities. Coenzyme A is an important coenzyme in cellular energy metabolism and is involved in multiple metabolic pathways, including glycolysis, fatty acid synthesis and oxidation, protein metabolism, etc. The accurate detection of its metabolic state is of great significance for understanding cellular energy metabolism, disease mechanisms and drug development.
[0003] However, the mass spectrometry signal of the existing detection method is low and the consumption of biological samples is large, resulting in the inability to detect coenzyme A-related substances when the sample amount is not easy to increase, such as mammalian functional cells. Summary of the invention
[0004] The purpose of the present invention is to provide a method for detecting coenzyme A and its metabolites by mass spectrometry of biological samples, aiming to solve the technical problem that the mass spectrometry signal of the detection method in the prior art is low, the consumption of biological samples is large, and when the sample amount is not easy to increase, such as mammalian functional cells, it is impossible to detect coenzyme A-related substances.
[0005] To achieve the above object, the present invention adopts a method for detecting coenzyme A and its metabolites by mass spectrometry of biological samples, comprising:
[0006] Obtain cell samples;
[0007] Obtain tissue cells;
[0008] Obtain body fluid tissue;
[0009] Rapid mass spectrometry detection of short-chain fatty acid-coenzyme A molecules is performed based on the obtained cell samples, tissue cells and body fluid tissues.
[0010] The specific methods for obtaining cell samples are as follows:
[0011] Wash the cells in the culture dish with 1xPBS;
[0012] Add about 1.5 mL of 5-15% TCA to the culture dish and incubate at -80°C;
[0013] After incubation, collect the cells in a centrifuge tube and vortex to mix;
[0014] The vortex-mixed cells were centrifuged at low temperature and the pellet was discarded;
[0015] Enrich the metabolites in the supernatant using an activated SPE column;
[0016] The impurities were washed with water, and eluted with methanol containing 10-30 mM ammonium acetate and the eluate was collected;
[0017] Drying the collected eluate;
[0018] After the eluate is dried, 50 μL of metabolite reconstitution solution is added for reconstitution, vortexed to mix, centrifuged at low temperature, and 40 μL of the supernatant is taken for injection.
[0019] Among them, the specific methods of obtaining tissue cells are as follows:
[0020] Take 30-100 mg of fresh mouse tissue, grind it into powder in a grinding mortar placed in liquid nitrogen, and collect the ground tissue;
[0021] Add approximately 1.5 mL of 5-15% TCA to the tissue powder and incubate at -80°C;
[0022] Use low temperature centrifugation and discard the precipitate;
[0023] Then, tissue cells can be obtained by SPE enrichment.
[0024] Among them, the specific methods of obtaining body fluid tissue are as follows:
[0025] Take 30-100 μL of mouse serum;
[0026] The mouse serum was supplemented to approximately 1.5 mL with 5-15% TCA and incubated at -80°C;
[0027] Use low temperature centrifugation and discard the precipitate;
[0028] Afterwards, SPE enrichment can be used to obtain body fluid tissue.
[0029] Among them, the method of rapid mass spectrometry detection of short-chain fatty acid-coenzyme A molecules based on the obtained cell samples, tissue cells and body fluid tissues is: LC-MS detection method.
[0030] The specific method of drying the collected eluate is to dry the eluate by blowing with nitrogen or by vacuum freeze concentration.
[0031] The present invention discloses a method for detecting Coenzyme A and metabolites by mass spectrometry of biological samples, which obtains cell samples, tissue cells, and body fluid tissues, and uses LC-MS detection method to perform rapid mass spectrometry detection of short-chain fatty acid-Coenzyme A molecules based on the obtained cell samples, tissue cells, and body fluid tissues, thereby completing rapid mass spectrometry detection of 20 short-chain fatty acid-Coenzyme A molecules in cell samples, body fluid tissues, and tissue cells. In this way, the technical problem that the mass spectrometry signal of the detection method in the prior art is low and the consumption of biological samples is large, resulting in the inability to detect Coenzyme A-related substances when the sample amount is not easy to increase, such as mammalian functional cells, is targeted;
[0032] The present invention has the following beneficial effects:
[0033] 1. The amount of biological samples required is small, and the cell volume is about 1x10 6 , tissue is about 50mg, suitable for almost all biological sample detection;
[0034] 2. The method is stable and can be applied to clinical sample testing. For example, after clinical samples are obtained, they can be stored in the extraction solution for 48 hours and then tested on the machine. There is no need to extract and test them immediately.
[0035] 3. Long retention time, can be detected within 48 hours;
[0036] 4. High signal, the analyte is easily ionized and detected, and the peak shape is standard;
[0037] 5. The single sample detection time is short (10min), which is conducive to the detection of large batches of samples. BRIEF DESCRIPTION OF THE DRAWINGS
[0038] In order to more clearly illustrate the embodiments of the present invention or the technical solutions in the prior art, the drawings required for use in the embodiments or the description of the prior art will be briefly introduced below. Obviously, the drawings described below are only some embodiments of the present invention. For ordinary technicians in this field, other drawings can be obtained based on these drawings without paying creative work.
[0039] Figure 1 It is a schematic diagram of the ion responses of six compounds under different mobile phase pH conditions of the present invention.
[0040] Figure 2 It is a schematic diagram of the ion responses of six compounds in the extracts of different TCA concentrations of the present invention.
[0041] Figure 3 It is a schematic diagram of the ion responses of six compounds under different extraction methods of the present invention.
[0042] Figure 4It is a schematic diagram of ion responses of four compounds under different storage temperature conditions after extraction of the present invention.
[0043] Figure 5 It is a schematic diagram comparing the detection time and number of the present invention and the existing mass spectrometry method.
[0044] Figure 6 It is a schematic diagram of the changes in coenzyme A related to fatty acid synthesis in mice under different diets of the present invention.
[0045] Figure 7 It is a schematic diagram of the labeling effect in the in vivo dual stable isotope labeling experiment of the present invention. DETAILED DESCRIPTION
[0046] Embodiments of the present invention are described in detail below. Examples of the embodiments are shown in the accompanying drawings. The embodiments described below with reference to the accompanying drawings are exemplary and are intended to be used to explain the present invention, but should not be construed as limiting the present invention.
[0047] See also Figure 1 to Figure 7 ,in Figure 1 is a schematic diagram of the ion responses of six compounds under different mobile phase pH conditions of the present invention, Figure 2 Schematic diagram of ion responses of six compounds in different TCA concentration extracts of the present invention. Figure 3 is a schematic diagram of the ion responses of six compounds under different extraction methods of the present invention, Figure 4 is a schematic diagram of ion responses of four compounds under different storage temperature conditions after extraction of the present invention, Figure 5 This is a schematic diagram comparing the detection time and number of the present invention and the existing mass spectrometry method. Figure 6 is a schematic diagram of the changes in coenzyme A related to fatty acid synthesis in mice under different diets of the present invention, Figure 7 It is a schematic diagram of the labeling effect in the in vivo dual stable isotope labeling experiment of the present invention.
[0048] The present invention provides a method for detecting coenzyme A and metabolites by mass spectrometry of a biological sample, comprising the following steps:
[0049] S100, obtaining cell samples;
[0050] For this specific embodiment, the specific method of obtaining the cell sample is as follows: washing the cells in the culture dish with 1xPBS;
[0051] Add about 1.5 mL of 5-15% TCA to the culture dish and incubate at -80°C;
[0052] After incubation, collect the cells in a centrifuge tube and vortex to mix;
[0053] The vortex-mixed cells were centrifuged at low temperature and the pellet was discarded;
[0054] Enrich the metabolites in the supernatant using an activated SPE column;
[0055] The impurities were washed with water, and eluted with methanol containing 10-30 mM ammonium acetate and the eluate was collected;
[0056] Drying the collected eluate;
[0057] After the eluate is dried, 50 μL of metabolite reconstitution solution is added for reconstitution, vortexed to mix, centrifuged at low temperature, and 40 μL of the supernatant is taken for injection.
[0058] S200, obtaining tissue cells;
[0059] According to this specific embodiment, the specific method of obtaining tissue cells is as follows: 30-100 mg of fresh mouse tissue is taken, ground into powder in a grinding mortar placed in liquid nitrogen, and the ground tissue is collected;
[0060] Add approximately 1.5 mL of 5-15% TCA to the tissue powder and incubate at -80°C;
[0061] Use low temperature centrifugation and discard the precipitate;
[0062] Then, tissue cells can be obtained by SPE enrichment.
[0063] S300, obtaining body fluid tissue;
[0064] For this specific embodiment, the specific method of obtaining body fluid tissue is as follows: 30-100 μL of mouse serum is taken;
[0065] The mouse serum was supplemented to approximately 1.5 mL with 5-15% TCA and incubated at -80°C;
[0066] Use low temperature centrifugation and discard the precipitate;
[0067] Afterwards, SPE enrichment can be used to obtain body fluid tissue.
[0068] S400, based on the obtained cell samples, tissue cells and body fluid tissues, uses LC-MS detection method to perform rapid mass spectrometry detection of short-chain fatty acid-coenzyme A molecules.
[0069] In LC-MS detection method:
[0070] Buffer A: acetonitrile: water = 5:95 (20 mM ammonium acetate) pH 6
[0071] Buffer B: 100% acetonitrile
[0072] Column: XBridge BEHAmide 2.5μm
[0073] 4.6X50mm Column XP
[0074] Machine: AB SCIEX 6500+
[0075] Elution gradient
[0076] Time(min) Buffer A (%) Buffer B 15 85 1.21 68 32 4.25 98 2 5.86 98 2 6.04 15 85 9.07 15 85
[0077] Injection volume: 10 μl
[0078] Flow rate: 0.4ml / min.
[0079] A method for detecting coenzyme A and metabolites using a biological sample mass spectrometry of the invention is used to obtain cell samples, tissue cells, and body fluid tissues, and to perform rapid mass spectrometry detection of short-chain fatty acid-coenzyme A molecules using LC-MS detection methods based on the obtained cell samples, tissue cells, and body fluid tissues, thereby completing rapid mass spectrometry detection of 20 short-chain fatty acid-coenzyme A molecules in cell samples, body fluid tissues, and tissue cells. In this way, the technical problem that the mass spectrometry signal of the detection method in the prior art is low and the consumption of biological samples is large, resulting in the inability to detect coenzyme A-related substances when the sample amount is not easy to increase, such as mammalian functional cells;
[0080] See also Figure 1 The present invention optimizes the pH value of the mobile phase, taking five Coenzyme A-related metabolites and Coenzyme A as examples, Figure 1 The ion responses of the six compounds under different pH conditions are shown, from which it can be seen that under the mobile phase condition of pH 6, the ion response of coenzyme A related compounds is the highest.
[0081] See also Figure 2 The present invention adopts trichloroacetic acid (TCA) extraction: the same mouse serum sample is extracted with TCA solution of different concentrations; taking 5 CoA-related metabolites and CoA as examples, Figure 2 The ion responses of these six compounds at different TCA concentrations are shown, from which it can be seen that 5%-15% TCA effectively improves the extraction efficiency of CoA-related metabolites.
[0082] See also Figure 3 The present invention adopts the SPE enrichment method and compares the SPE enrichment method with two commonly used methods for extracting metabolites. Taking five CoA-related metabolites and CoA as examples, Figure 3 The ion responses of these six compounds under different extraction methods are shown, from which it can be seen that compared with the conventional metabolite extraction method, the SPE enrichment method effectively enriched the CoA-related metabolites.
[0083] See also Figure 4 The present invention optimizes the storage temperature, and stores the extracted substances at 4°C, -20°C, and -80°C for 24 hours, and compares them with the samples immediately loaded on the machine after extraction (0h), to find out the best storage conditions for the samples. Figure 4 It can be seen that coenzyme A-related compounds have the problem of gradual degradation over time, and the optimal storage temperature is -80°C.
[0084] See also Figure 5 , the present invention optimizes the detection time and the number of detections, by Figure 5 It can be seen that the present invention improves the mass spectrometry detection time, can detect a sample within 10 minutes, and can detect 20 coenzyme A related compounds.
[0085] Example 1: The present invention was used to detect the changes in coenzyme A-related metabolites in mice under different dietary conditions (normal feed and high-fat feed). The results are as follows: Figure 6 As shown, it can be seen that feeding mice with different diets does indeed lead to an upregulation or downregulation of the amount of coenzyme A related to fatty acid synthesis.
[0086] Example 2: Based on the present invention, an in vivo dual stable isotope labeling experiment was designed to simultaneously monitor the metabolism of free fatty acids and fructose in the mouse heart. Specifically, on the basis of this method, an isotope ion pair was added, deuterated oleic acid or 13C fructose was intravenously injected into the mouse, and the mouse heart was removed at 0, 5, 10 or 20 minutes to detect the changes in the labeling ratio of coenzyme A related metabolites. The results are as follows: Figure 7 As shown, it can be seen that this method can effectively detect both deuterated oleic acid and 13C fructose for labeling of coenzyme A-related metabolites in mouse heart.
[0087] The present invention has the following beneficial effects:
[0088] 1. The amount of biological samples required is small, and the cell volume is about 1x10 6 , tissue is about 50mg, suitable for almost all biological sample detection;
[0089] 2. The method is stable and can be applied to clinical sample testing. For example, after clinical samples are obtained, they can be stored in the extraction solution for 48 hours and then tested on the machine. There is no need to extract and test them immediately.
[0090] 3. Long retention time, can be detected within 48 hours;
[0091] 4. High signal, the analyte is easily ionized and detected, and the peak shape is standard;
[0092] 5. The single sample detection time is short (10min), which is conducive to the detection of large batches of samples.
[0093] What is disclosed above is only a preferred embodiment of the present invention, and it certainly cannot be used to limit the scope of rights of the present invention. Ordinary technicians in this field can understand that all or part of the processes of the above embodiment and equivalent changes made according to the claims of the present invention still fall within the scope of the invention.
Claims
1. A method for detecting coenzyme A and its metabolites by mass spectrometry of biological samples, It is characterized in that include: Obtain cell samples; Obtain tissue cells; Obtain body fluid tissue; Rapid mass spectrometry detection of short-chain fatty acid-coenzyme A molecules is performed based on the obtained cell samples, tissue cells and body fluid tissues.
2. The method for detecting coenzyme A and its metabolites by mass spectrometry of biological samples according to claim 1, It is characterized in that The specific methods for obtaining cell samples are as follows: Wash the cells in the culture dish with 1xPBS; Add about 1.5 mL of 5-15% TCA to the culture dish and incubate at -80°C; After incubation, collect the cells in a centrifuge tube and vortex to mix; The vortex-mixed cells were centrifuged at low temperature and the pellet was discarded; Enrich the metabolites in the supernatant using an activated SPE column; The impurities were washed with water, and eluted with methanol containing 10-30 mM ammonium acetate and the eluate was collected; Drying the collected eluate; After the eluate is dried, 50 μL of metabolite reconstitution solution is added for reconstitution, vortexed to mix, centrifuged at low temperature, and 40 μL of the supernatant is taken for injection.
3. The method for detecting coenzyme A and its metabolites by mass spectrometry of biological samples as claimed in claim 2, It is characterized in that The specific methods for obtaining tissue cells are as follows: Take 30-100 mg of fresh mouse tissue, grind it into powder in a grinding mortar placed in liquid nitrogen, and collect the ground tissue; Add approximately 1.5 mL of 5-15% TCA to the tissue powder and incubate at -80°C; Use low temperature centrifugation and discard the precipitate; Then, tissue cells can be obtained by SPE enrichment.
4. The method for detecting coenzyme A and its metabolites by mass spectrometry of biological samples as claimed in claim 3, It is characterized in that The specific methods of obtaining body fluid tissue are as follows: Take 30-100 μL of mouse serum; The mouse serum was supplemented to approximately 1.5 mL with 5-15% TCA and incubated at -80°C; Use low temperature centrifugation and discard the precipitate; Afterwards, SPE enrichment can be used to obtain body fluid tissue.
5. The method for detecting coenzyme A and its metabolites by mass spectrometry of biological samples as claimed in claim 4, It is characterized in that The method of rapid mass spectrometry detection of short-chain fatty acid-coenzyme A molecules based on the obtained cell samples, tissue cells and body fluid tissues is: LC-MS detection method.
6. The method for detecting coenzyme A and its metabolites by mass spectrometry of a biological sample as claimed in claim 5, It is characterized in that The specific method for drying the collected eluate is to dry the eluate by blowing with nitrogen or by vacuum freeze concentration.
